NDC 72934-2098

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%

Hyaluronic Acid Sodium Salt 2% / Mometasone Furoate 0.1% / Niacinamide 4%

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Hyaluronic Acid; Mometasone Furoate; Niacinamide.

Product ID72934-2098_8967cd2b-c0a5-8df1-e053-2a95a90a3670
NDC72934-2098
Product TypeHuman Prescription Drug
Proprietary NameHYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
Generic NameHyaluronic Acid Sodium Salt 2% / Mometasone Furoate 0.1% / Niacinamide 4%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-21
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameHYALURONIC ACID; MOMETASONE FUROATE; NIACINAMIDE
Active Ingredient Strength2 g/100g; g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2098-2

30 g in 1 BOTTLE, PUMP (72934-2098-2)
Marketing Start Date2019-05-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2098-2 [72934209802]

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-21

Drug Details

Active Ingredients

IngredientStrength
HYALURONIC ACID2 g/100g

OpenFDA Data

SPL SET ID:8967cd2b-c0a4-8df1-e053-2a95a90a3670
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.